Insmed (INSM) Change in Account Payables (2010 - 2022)
Insmed's (INSM) quarterly Change in Account Payables came in at -$16.9 million in Q2 2022, down 285.64% year-on-year from $9.1 million in Q2 2021, and down 226.63% quarter-over-quarter from $13.4 million in Q1 2022.
Insmed (INSM) Change in Account Payables (2010 - 2022) Analysis & Trends
Insmed's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$16.9 million for Q2 2022.
- On a quarterly basis, Change in Account Payables fell 285.64% year-over-year to -$16.9 million in Q2 2022; TTM through Jun 2022 was $25000.0, a 99.61% decrease from a year earlier, with the FY2024 full-year figure at $44.6 million, up 194.24% from the prior year.
- Change in Account Payables declined to -$16.9 million in Q2 2022 per INSM's latest filing, from $13.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $20.7 million in Q4 2020 and bottomed at -$20.3 million in Q1 2021.
- The 5-year median for Change in Account Payables is $2.0 million (2018), against an average of $977555.6.
- Across the five-year window, Change in Account Payables jumped 1247.22% in 2019 and plunged 586.28% in 2021, its largest moves.
- Year by year, Change in Account Payables stood at $1.3 million in 2018, then slumped by 577.96% to -$6.4 million in 2019, then soared by 424.73% to $20.7 million in 2020, then sank by 45.53% to $11.3 million in 2021, then tumbled by 250.02% to -$16.9 million in 2022.
- Per Business Quant, the three latest INSM Change in Account Payables figures stand at -$16.9 million (Q2 2022), $13.4 million (Q1 2022), and $11.3 million (Q4 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -16.92 Mn |
| Jun 30, 2022 | -16.92 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | -7.70 Mn |
| Sep 30, 2021 | -7.70 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Mar 31, 2021 | -20.27 Mn |
| Mar 31, 2021 | -20.27 Mn |
| Dec 31, 2020 | 20.71 Mn |
| Dec 31, 2020 | 20.71 Mn |
| Sep 30, 2020 | -3.06 Mn |
| Sep 30, 2020 | -3.06 Mn |
| Jun 30, 2020 | 8.01 Mn |
| Jun 30, 2020 | 8.01 Mn |
| Mar 31, 2020 | 4.17 Mn |
| Mar 31, 2020 | 4.17 Mn |